Showing results (91-100 of 636) with videos related to
Sort By:
Pageof 64
Neurodegenerative Disease Management|May 20, 2021
Ozanimod for the treatment of relapsing forms of multiple sclerosisAndrea M Kuczynski, Jiwon OhFrontiers in Immunology|January 1, 2024
Bioavailable central nervous system disease-modifying therapies for multiple sclerosisHans-Peter Hartung, Bruce A C Cree, Michael Barnett, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Dendritic cell differentiation signals induce anti-inflammatory properties in human adult microgliaCaroline Lambert, Julie Desbarats, Nathalie Arbour, et al.Frontiers in Immunology|January 19, 2016
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple SclerosisRui Li, Ayman Rezk, Luke M Healy, et al.Frontiers in Neurology|March 17, 2022
Vaccine Response in Patients With Multiple Sclerosis Receiving TeriflunomideCarlo Tornatore, Heinz Wiendl, Alex L Lublin, et al.The Lancet. Neurology|October 5, 2013
Emerging injectable therapies for multiple sclerosisJiwon Oh, Peter A CalabresiNature Reviews. Neurology|January 14, 2015
Multiple sclerosis in 2014. Progress in MS--classification, mechanisms and treatmentJiwon Oh, Paul W O'ConnorTherapeutic Advances in Neurological Disorders|October 25, 2014
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospectsJiwon Oh, Paul W O'ConnorCurrent Opinion in Neurology|April 30, 2015
Established disease-modifying treatments in relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'ConnorCurrent Opinion in Neurology|April 19, 2015
Novel and imminently emerging treatments in relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'ConnorPageof 64